Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D04TNI
|
|||
Drug Name |
Nitroflurbiprofen
|
|||
Synonyms |
Flurbinitroxybutylester; Flurbiprofen nitroxybutylester; HCT 1026; NO-flurbiprofen
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1], [2], [3] | |
Structure |
Download2D MOL |
|||
Formula |
C19H20FNO5
|
|||
Canonical SMILES |
CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)OCCCCO[N+](=O)[O-]
|
|||
InChI |
1S/C19H20FNO5/c1-14(19(22)25-11-5-6-12-26-21(23)24)16-9-10-17(18(20)13-16)15-7-3-2-4-8-15/h2-4,7-10,13-14H,5-6,11-12H2,1H3
|
|||
InChIKey |
DLWSRGHNJVLJAH-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 158836-71-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:77428
|
References | Top | |||
---|---|---|---|---|
REF 1 | The cyclooxygenase inhibitor flurbiprofen reduces radiation-induced angiogenic growth factor secretion of squamous cell carcinoma cell lines. Ann N Y Acad Sci. 2004 Dec;1030:37-42. | |||
REF 2 | Flurbiprofen, a cyclooxygenase inhibitor, protects mice from hepatic ischemia/reperfusion injury by inhibiting GSK-3 signaling and mitochondrial permeability transition.Mol Med.2012 Sep 25;18:1128-35. | |||
REF 3 | Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis.Ocul Immunol Inflamm.2016;24(1):35-42. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.